Chapter 7 : O139 Bengal

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

O139 Bengal, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818364/9781555810672_Chap07-1.gif /docserver/preview/fulltext/10.1128/9781555818364/9781555810672_Chap07-2.gif


Beginning in October 1992, cases of cholera-like disease associated with a strain that did not agglutinate with O1 antisera were noted in Madras, India. The emergence of O139 demonstrates that the O1 antigen is not an exclusive marker for epidemic potential and underscores the need to better understand the interplay of genetic and epidemiologic factors that allow strains to spread rapidly through populations. O139 Bengal does not agglutinate with monoclonal or polyclonal antisera directed against the O1 antigen. DNA sequences of 16S rRNA (positions 330 to 615) from these isolates are typical for O1 strains. O139 carries the gene for and expresses cholera toxin. Monoclonal and polyclonal antisera directed against the O139 antigen are available on a limited, experimental basis; such antisera should be available commercially in the near future. As with O1, the mainstay of therapy for diarrheal disease is oral rehydration. Since resistance to antimicrobial agents is in most instances plasmid mediated, it may be only a matter of time before tetracycline resistance is acquired by O139 strains.

Citation: Morris, Jr. J, Cholera Laboratory Task Force*. 1994. O139 Bengal, p 95-102. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch7
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Electron photomicrograph of thin sections of O139 Bengal strained with polycationic ferritin, showing capsular polysaccharide.

Citation: Morris, Jr. J, Cholera Laboratory Task Force*. 1994. O139 Bengal, p 95-102. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch7
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Albert, M. J.,, A. K. Siddique,, M. S. Islam,, A. S. G. Faruque,, M. Ansaruzzaman,, S. M. Faruque,, and R. B. Sack. 1993. A large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet 341: 704.
2. Barua, D., 1992. History of cholera, p. 1 36. In D. Barua, and W. B. Greenough III (ed.), Cholera. Plenum Medical Book Co., New York.
3. Baudry, B.,, A. Fasano,, J. Ketley,, and J. B. Ka-per. 1992. Cloning of a gene ( zot) encoding a new toxin produced by Vibrio cholerae. Infect. Immun. 60: 428 434.
4. Centers for Disease Control and Prevention. 1993. Imported cholera associated with a newly described toxigenic Vibrio cholerae O139 strain—California, 1993. Morbid. Mortal. Weekly Rep. 42: 501503.
5. Chongsa-Nguan, M.,, W. Chaicumpa,, P. Mool-asart,, P. Kandhasingha,, T. Shimada,, H. Kurazono,, and Y. Takeda. 1993. Vibrio cholerae O139 in Bangkok. Lancet 342: 430 431.
6. Dutt, A. K.,, S. Alwi,, and T. Velauthan. 1971. A shellfish-borne cholera outbreak in Malaysia. Trans. R. Soc. Trop. Med. Hyg. 65: 815 818.
7. Fields, P. I.,, M. Tamplin, and Ø. Olsvik. 1993. DNA sequence heterogeneity within the genes encoding cholera toxin. Program Abstr. 29th Joint Conf. Cholera Related Diarrheal Dis.
8. Finch, M. J.,, J. G. Morris, Jr.,, J. Kaviti,, W. Kagwanja,, and M. M. Levine. 1988. Molecular epidemiology of antimicrobial-resistant cholera in Kenya and East Africa. Am. J. Trop. Med. Hyg. 39: 484 490.
9. Gardner, A. D.,, and V. K. Venkatraman. 1935. The antigens of the cholera group of vibrios. J. Hyg. 35: 262 282.
10. Glass, R. I.,, S. Becker,, M. I. Huq,, B. J. Stoll,, M. U. Khan,, M. H. Merson,, J. V. Lee,, and R. E. Black. 1982. Endemic cholera in rural Bangladesh, 1966-1980. Am. J. Epidemiol. 116: 959 970.
11. Goldberg, I.,, and J. J. Mekalanos. 1986. Effect of a recA mutation on cholera toxin gene amplification and deletion events. J. Bacteriol. 165: 723 731.
12. Hall, R. H.,, F. M. Khambaty,, M. Kothary,, and S. R Keasler. 1993. Non-O1 Vibrio cholerae. Lancet 342: 430.
13. International Center for Diarrheal Disease Research, Bangladesh, Cholera Working Group. 1993. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Lancet 342: 387390.
14. Islam, M. S.,, M. K. Hasan,, M. A. Miah,, F. Qadri,, M. Yunus,, R. B. Sack,, and M. J. Albert. 1993. Isolation of Vibrio cholerae O139 Bengal from water in Bangladesh. Lancet 342: 430.
15. Jesudason, M. V.,, A. M. Cherian,, and T. J. John. 1993. Blood stream invasion by Vibrio cholerae O139. Lancet 342: 431.
16. Johnson, J. A.,, M. J. Albert,, R. Panigrahi,, A. C. Wright,, A. Joseph,, L. Comstock,, M. Trucksis,, J. Michalski,, R. J. Johnson,, J. B. Kaper,, and J. G. Morris, Jr. 1993. Non-O1 Vibrio cholerae (O139 synom. Bengal) from the India/Bangladesh epidemic are encapsulated. Program Abstr. 29th Joint Conf. Cholera Related Diarrheal Dis.
17. Johnson, J. A.,, A. Joseph,, P. Panigrahi,, and J. G. Morris, Jr. 1992. Frequency of encapsulated versus unencapsulated strains of non-O1 Vibrio cholerae isolated from patients with septicemia or diarrhea, or from environmental sources, abstr. B-277, p. 72. Abstr. 92nd Gen. Meet. Am. Soc. Microbiol. 1992.
18. Johnson, J. A.,, P. Panigrahi,, and J. G. Morris, Jr. 1992. Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect. Immun. 60: 684 689.
19. Kaper, J. B.,, H. Lockman,, R. R. Colwell,, and S. W. Joseph. 1979. Ecology, serology, and enterotoxin production of Vibrio cholerae in Chesapeake Bay. Appl. Environ. Microbiol. 37: 91 103.
20. Kelly, M. T.,, F. W. Hickman-Brenner,, and J. J. Farmer III,. 1991. Vibrio, p. 384 395. In A. Balows,, W. J. Hausler, Jr.,, K. L. Herrmann,, H. D. Isenberg,, and H. J. Shadomy (ed.), Manual of Clinical Microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
21. Momen, H.,, and C. A. SaUes. 1985. Enzyme markers for Vibrio cholerae: identification of classical, El Tor, and environmental strains. Trans. R. Soc. Trop. Med. Hyg. 79: 773 776.
22. Pollitzer, R. 1959. Cholera. World Health Organization, Geneva.
23. Popovic, T.,, C. Bopp,, 0. Olsvik,, and K. Wachs-muth. 1993. Epidemiologic application of a standardized ribotype scheme for Vibrio cholerae O1. J. Clin. Microbiol. 31: 2474 2482.
24. Popovic, T.,, P. I. Fields,, O. Olsvik,, J. G. Wells,, G. M. Evins,, D. N. Carmeron,, K. Wachsmuth,, R. B. Sack,, J. M. Albert,, N. Balakrish,, and J. C. Feeley. 1993. Program Abstr. 29th Joint Conf. Cholera and Related Diarrheal Dis.
25. Ramamurthy, T.,, S. Garg,, R. Sharma,, S. K. Bhattacharya,, G. B. Nair,, T. Shimada,, T. Takeda,, T. Karasawa,, H. Kurazano,, A. Pal,, and Y. Takeda. 1993. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 341: 703 704.
26. Roberts, N. C.,, R. J. Seibeling,, J. B. Kaper,, and H. B. Bradford. 1982. Vibrios in the Louisiana Gulf Coast environment. Microb. Ecol. 8: 299 312.
27. Safrin, S.,, J. G. Morris, Jr.,, M. Adams,, V. Pons,, R. Jacobs,, and J. E. Conte, Jr. 1988. Non-0:1 Vibrio cholerae bacteremia: case report and review. Rev. Infect. Dis. 10: 1012 1017.
28. Sakazaki, R.,, and T. Shimada. 1977. Serovars of Vibrio cholerae. Jpn. J. Med. Sci. Biol. 30: 279 282.
29. Salles, C. A.,, A. R. da Silva,, and H. Momen. 1986. Enzyme typing and phenetic relationships in Vibrio cholerae. Rev. Brasil Genet. 9: 407 419.
30. Salles, C. A.,, and J. G. Morris, Jr. Unpublished data.
31. Shehabi, A. A.,, A. B. Abu Rajab,, and A. A. Shaker. 1980. Observations on the emergence of non-cholera vibrios during an outbreak of cholera. Jordan Med. J. 14: 125 127.
32. Siebeling, R. J.,, L. B. Adams,, Z. Yusof,, and A. D. Larson,. 1984. Antigens and serovar-specific antigens of Vibrio cholerae, p. 33 58. In R. R. Colwell (ed.), Vibrios in the Environment. John Wiley & Sons, Inc., New York.
33. Smith, H. L., Jr. 1979. Serotyping of non-cholera vibrios. J. Clin. Microbiol. 10: 85 90.
34. Swerdlow, D. L.,, E. D. Mintz,, M. Rodriguez,, E. Tejada,, C. Ocampo,, L. Espejo,, K. D. Greene,, W. Saldana,, L. Seminario,, R. V. Tauxe,, J. G. Wells,, N. H. Bean,, A. A. Ries,, M. Pollack,, B. Vertiz,, and P. A. Blake. 1992. Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk. Lancet 340: 28 32.
35. Swerdlow, D. L.,, and A. A. Ries. 1993. Vibrio cholerae non-O1—the eighth pandemic? Lancet 342: 382 383.
36. Trucksis, M.,, J. E. Galen,, J. Michalski,, A. Fasano,, and J. B. Kaper. 1993. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc. Natl. Acad. Sci. USA 90: 5267 5271.
37. Wachsmuth, I. K.,, G. M. Evins,, P. I. Fields,, O. Olsvik,, T. Popovic,, C. A. Bopp,, J. G. Wells,, C. Carrillo,, and P. A. Blake. 1993. The molecular epidemiology of cholera in Latin America. J. Infect. Dis. 167: 621 626.
38. Wright, A. C.,, Y. Guo,, J. A. Johnson,, J. P. Nataro,, and J. G. Morris, Jr. 1992. Development and testing of a non-radioactive DNA oligonucleotide probe that is specific for Vibrio cholerae toxin. J. Clin. Microbiol. 30: 2302 2306.


Generic image for table
Table 1

Clinical signs and symptoms of patients with acute diarrhea associated with O139

Citation: Morris, Jr. J, Cholera Laboratory Task Force*. 1994. O139 Bengal, p 95-102. In Wachsmuth I, Blake P, Olsvik Ø (ed), and Cholera. ASM Press, Washington, DC. doi: 10.1128/9781555818364.ch7

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error